Lowering of systolic blood pressure in hypertensive patients: insights and questions from the ESPRIT study

• Reinhold Kreutz,
• Mattias Brunström,
• Sverre E. Kjeldsen,
• Krzysztof Narkiewicz,
• Brent Egan,
• Michel Burnier

Affiliations

Reinhold Kreutz

Institute of Clinical Pharmacology and Toxicology, Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany

Mattias Brunström

Department of Public Health and Clinical Medicine, Umeå University, Sweden

Sverre E. Kjeldsen

Departments of Cardiology and Nephrology, University of Oslo, Ullevaal Hospital, Oslo, Norway

Krzysztof Narkiewicz

Department of Hypertension and Diabetology, Medical University of Gdansk, Poland

Brent Egan

University of South Carolina, Greenville, USA

Michel Burnier

Faculty of Biology and Medicine, University of Lausanne, Switzerland